Sanofi-Aventis Canada Inc. v. Novopharm Limited, 2012 FCA 265 (Ramipril*)
Justice Sharlow; Justice Dawson; Justice Trudel - 2012-10-23
Read full decision. Automatically generated summary:
We have today heard nine appeals and four cross-appeals from judgments and orders of Justice Snider relating to her previous judgments dismissing actions seeking a remedy against Apotex Inc. ("Apotex"), and against Novopharm Limited and its successor Teva Canada Limited ("Teva"), for the infringement of Canadian Patent No. 1,341,206. The plaintiffs in the actions were Sanofi-Aventis Canada Inc. and Sanofi-Aventis Deutschland GmbH ("Sanofi"), the licensee of the patent, and Schering Corporation ("Schering"), the holder of the patent. Justice Snider subsequently dealt with various motions relating to costs. Her disposition of those motions is the subject of the appeals and cross-appeals now before us.
Decision relates to:
- A-369-10 - SANOFI-AVENTIS CANADA INC. ET AL v. TEVA CANADA LTD ET AL which is an appeal from a decision dated 2010-09-28 in T-1161-07
- A-379-10 - SCHERING CORPORATION v. TEVA CANADA LIMITED ET AL. which is an appeal from a decision dated 2010-09-28 in T-1161-07
- A-406-10 - SANOFI-AVENTIS CANADA INC. ET AL v. TEVA CANADA LIMITED ET AL which is an appeal from a decision dated 2010-10-15 in T-1161-07
- A-417-10 - SANOFI-AVENTIS CANADA INC. ET AL v. TEVA CANADA LIMITED ET AL which is an appeal from a decision dated 2010-10-25 in T-1161-07
- A-418-10 - SCHERING CORPORATION v. TEVA CANADA LTD ET AL
- A-484-09 - SANOFI-AVENTIS CANADA INC. ET AL v. NOVOPHARM LTD. ET AL which is an appeal from 2009 FC 1139 in T-1161-07
- A-485-09 - SANOFI-AVENTIS CANADA INC. ET AL v. APOTEX INC. ET AL which is an appeal from 2009 FC 1138 in T-161-07
- A-486-09 - SCHERING CORPORATION ET AL v. SANOFI-AVENTIS CANADA INC. ET AL which is an appeal from 2009 FC 1138 in T-161-07
- A-489-09 - SCHERING CORPORATION v. NOVOPHARM LIMITED ET AL which is an appeal from 2009 FC 1139 in T-1161-07